Immunotherapeutic Approaches in Triple-Negative Breast Cancer: State of the Art and Future Perspectives

Triple-negative breast cancer (TNBC) is characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). It accounts for 15%–20% of all breast cancers and is associated with an aggressive evolution and poor outcomes with the maj...

Descripción completa

Detalles Bibliográficos
Autores principales: Oualla, Karima, Kassem, Loay, Nouiakh, Lamiae, Amaadour, Lamiae, Benbrahim, Zineb, Arifi, Samia, Mellas, Nawfel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661147/
https://www.ncbi.nlm.nih.gov/pubmed/33204535
http://dx.doi.org/10.1155/2020/8209173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661147/
https://www.ncbi.nlm.nih.gov/pubmed/33204535
http://dx.doi.org/10.1155/2020/8209173

Ejemplares similares